Liza Takiya

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)

Joel Schlessinger, Julie S. Shepard, Richard Gower et al. · American Journal of Clinical Dermatology · 2020 · 88 citations · Full text

Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis.

Jeffrey R. Curtis, Hendrik Schulze‐Koops, Liza Takiya et al. · PubMed · 2017 · 69 citations

A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population

Alan Kivitz, Stanley Cohen, Edward Keystone et al. · Seminars in Arthritis and Rheumatism · 2018 · 44 citations · Full text

Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis

George Reed, Robert A. Gerber, Ying Shan et al. · Rheumatology and Therapy · 2019 · 44 citations · Full text